Fundz
Back to Investors

Track Eli Lilly And Company's Investment Activity

Get real-time alerts when Eli Lilly And Company makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $49/mo
E

Eli Lilly And Company

Corporate VC
www.lilly.com/science/partners/catalyze-360
Total Deals
34
Recent (90d)
7
Total Capital
$3.4B
Co-Investors
183
Pitch this inbox directly

Checked the Catalyze360 and connect-with-us pages. Catalyze360 is the umbrella over Lilly Ventures, Gateway Labs, ExploR and D, and TuneLab, and its only call to action points to the connect page. That page publishes direct addresses for Lilly's corporate business development search and evaluation leads by therapeutic area, covering devices and delivery, diabetes and obesity, digital health, genetic medicines, immunology, biologics, neuroscience and oncology. The Lilly Ventures block names five people but carries no email, no link and no form.

Worth knowing. Lilly Ventures is deliberately unreachable on its own terms. The published door is science first, through the search and evaluation lead for your therapeutic area, and equity is only one of the engagement models Catalyze360 can attach afterwards. Pick the area lead precisely, because there is no generic inbox to fall back on.

How they invest
$50.0M
Median round they join
30
Companies backed
7
Checks in 90 days
Aug 17, 2026
Most recent check
Stages they write into
Series B 10Seed 7Series A 6Series C 5Funding Round 3

Built from 34 rounds we recorded since Jan 31, 2023.

Raising right now?

See every fund writing checks into companies like yours, ranked, each with a route in.

Build my investor list
L

Leal Therapeutics

BiotechnologyWorcester, United States
series a
$30.0M

Aug 17, 2026

A

Amplifica Holdings Group

BiotechnologySan Diego, United States
series b
$26.0M

Aug 12, 2026

R

Ratio Therapeutics

BiotechnologyBoston, United States
series c
$70.0M

Jul 31, 2026

F

Flare Therapeutics

BiotechnologyCambridge, United States
series c
$85.0M

Jun 30, 2026

L

Lycia Therapeutics, Inc.

Biotechnology
series d
$75.0M

Jun 25, 2026

29+ more investments

View all 34 deals by Eli Lilly And Company

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity and website modifications, based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.

Fundz tracks 45,000 investors and their 13F holdings, alongside every round the companies they back raise.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.